Who owns SILVERBACK THERAPEUTICS?
- Ticker: SPRY
- CUSIP Number: 82835w108
Tip: Access positions for across all investors
Analyze quarterly positions in Silverback Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Silverback Therapeutics stock
Who bought or sold SILVERBACK THERAPEUTICS this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Deerfield Management Company | 11M | $113M | 0% | Mar 2024 |
|
RA Capital Management | 11M | $111M | 15% | Mar 2024 |
|
OrbiMed Advisors | 9.2M | $94M | 0% | Mar 2024 |
|
Sr One Capital Management | 4.0M | $22M | 0% | Dec 2023 |
|
K2 Principal Fund | 3.7M | $20M | 14% | Dec 2023 |
|
Franklin Resources | 3.0M | $30M | -28% | Mar 2024 |
|
Vanguard Group | 2.9M | $30M | 37% | Mar 2024 |
|
BlackRock | 2.7M | $27M | 4% | Mar 2024 |
|
Nextech Invest | 1.9M | $20M | 0% | Mar 2024 |
|
FMR | 1.1M | $11M | -17% | Mar 2024 |
|
Geode Capital Management | 877k | $9.0M | 9% | Mar 2024 |
|
Perceptive Advisors | 867k | $8.9M | 100% | Mar 2024 |
|
Rubric Capital Management | 639k | $6.5M | 0% | Mar 2024 |
|
Royce & Associates | 559k | $5.7M | 18% | Mar 2024 |
|
Sio Capital Management | 536k | $5.5M | -52% | Mar 2024 |
|
Goldman Sachs Group | 463k | $4.7M | 228% | Mar 2024 |
|
Woodline Partners | 402k | $4.1M | -53% | Mar 2024 |
|
Charles Schwab Investment Management | 345k | $3.5M | 5% | Mar 2024 |
|
Susquehanna International | 306k | $3.1M | -42% | Mar 2024 |
|
Jacobs Levy Equity Management | 278k | $2.8M | 1280% | Mar 2024 |
|
Dimensional Fund Advisors | 275k | $2.8M | -15% | Mar 2024 |
|
ClariVest Asset Management | 273k | $2.8M | 100% | Mar 2024 |
|
Northern Trust | 262k | $2.7M | 0% | Mar 2024 |
|
DAFNA Capital Management | 239k | $2.4M | -23% | Mar 2024 |
|
Citadel Advisors | 179k | $1.8M | 51% | Mar 2024 |
|
GSA Capital Partners | 129k | $1.3M | 12% | Mar 2024 |
|
Rafferty Asset Management | 112k | $1.1M | 100% | Mar 2024 |
|
UBS Group | 104k | $1.1M | 5944% | Mar 2024 |
|
AWM Investment Company | 100k | $1.0M | 100% | Mar 2024 |
|
Morgan Stanley | 98k | $1.0M | 16% | Mar 2024 |
|
Nuveen Asset Management | 98k | $997k | -13% | Mar 2024 |
|
Citigroup | 98k | $996k | 1760% | Mar 2024 |
|
Jane Street | 92k | $944k | 5% | Mar 2024 |
|
Bank of America Corporation | 82k | $834k | -17% | Mar 2024 |
|
American Century Companies | 81k | $828k | 57% | Mar 2024 |
|
Arrowstreet Capital, Limited Partnership | 81k | $826k | 100% | Mar 2024 |
|
Capstone Investment Advisors | 72k | $739k | 100% | Mar 2024 |
|
Bank of New York Mellon | 70k | $714k | -17% | Mar 2024 |
|
ALPS Advisors | 66k | $364k | -6% | Dec 2023 |
|
Swiss National Bank | 66k | $675k | 0% | Mar 2024 |
|
Wealth Enhancement Advisory Services | 64k | $652k | 0% | Mar 2024 |
|
Alliancebernstein | 63k | $344k | 0% | Dec 2023 |
|
Financial Advisory Service | 61k | $618k | 32% | Mar 2024 |
|
Levin Capital Strategies | 55k | $565k | 6% | Mar 2024 |
|
Jpmorgan Chase & Co | 50k | $513k | 45% | Mar 2024 |
|
State of Wisconsin Investment Board | 41k | $423k | 34% | Mar 2024 |
|
D. E. Shaw & Co | 38k | $390k | 100% | Mar 2024 |
|
Rhumbline Advisers | 37k | $379k | 2% | Mar 2024 |
|
Letko, Brosseau & Associates | 36k | $368k | 0% | Mar 2024 |
|
Ameriprise Financial | 35k | $353k | -78% | Mar 2024 |
|
California State Teachers Retirement System | 33k | $334k | -16% | Mar 2024 |
|
Creative Planning | 32k | $331k | 4% | Mar 2024 |
|
Honkamp Krueger Financial Services | 32k | $329k | 0% | Mar 2024 |
|
Balyasny Asset Management | 30k | $311k | 75% | Mar 2024 |
|
Barclays | 30k | $306k | -26% | Mar 2024 |
|
Credit Suisse | 30k | $302k | 0% | Mar 2024 |
|
Legal & General Group | 28k | $283k | -2% | Mar 2024 |
|
HighTower Advisors | 25k | $253k | 64% | Mar 2024 |
|
Janney Montgomery Scott | 25k | $250k | 4% | Mar 2024 |
|
Henderson Group | 22k | $223k | 0% | Mar 2024 |
|
Two Sigma Investments | 20k | $209k | -67% | Mar 2024 |
|
Virtu Financial | 20k | $206k | 100% | Mar 2024 |
|
Atlantic Trust | 20k | $189k | 100% | Mar 2024 |
|
Wolverine Trading | 20k | $199k | 100% | Mar 2024 |
|
China Universal Asset Management | 19k | $189k | 66% | Mar 2024 |
|
ProFund Advisors | 17k | $178k | 100% | Mar 2024 |
|
Ohio Pers | 17k | $172k | 100% | Mar 2024 |
|
Deutsche Bank Aktiengesellschaft | 15k | $151k | -3% | Mar 2024 |
|
J.w. Cole Advisors | 14k | $142k | 100% | Mar 2024 |
|
MetLife Investment Advisors | 14k | $76k | 0% | Dec 2023 |
|
Ubs Global Asset Management Americas | 13k | $132k | 0% | Mar 2024 |
|
Qube Research & Technologies | 13k | $129k | 100% | Mar 2024 |
|
American International | 12k | $67k | 1% | Dec 2023 |
|
New York State Common Retirement Fund | 12k | $123k | 0% | Mar 2024 |
|
SG Americas Securities | 12k | $119k | 100% | Mar 2024 |
|
ProShare Advisors | 11k | $114k | 100% | Mar 2024 |
|
Mirabella Financial Services | 10k | $105k | 100% | Mar 2024 |
|
Sunrise Partners Limited Partnership | 10k | $103k | 100% | Mar 2024 |
|
Wells Fargo & Company | 8.6k | $88k | 15% | Mar 2024 |
|
Russell Investments | 5.9k | $60k | 100% | Mar 2024 |
|
NISA Investment Advisors | 5.6k | $57k | 0% | Mar 2024 |
|
Zurcher Kantonalbank | 2.9k | $30k | -37% | Mar 2024 |
|
Signature | 2.8k | $29k | 0% | Mar 2024 |
|
Salomon & Ludwin | 2.8k | $29k | 0% | Mar 2024 |
|
Royal Bank of Canada | 2.2k | $23k | -73% | Mar 2024 |
|
Quantbot Technologies | 2.1k | $22k | 100% | Mar 2024 |
|
Summit Investment Advisors | 2.0k | $21k | 0% | Mar 2024 |
|
FinTrust Capital Advisors | 2.0k | $20k | 100% | Mar 2024 |
|
Park Circle | 2.0k | $20k | 0% | Mar 2024 |
|
Allspring Global Investments Holdings | 1.5k | $15k | -52% | Mar 2024 |
|
Metropolitan Life Insurance Company | 1.4k | $7.8k | 0% | Dec 2023 |
|
Steward Partners Investment Advisory | 1.3k | $13k | 0% | Mar 2024 |
|
Aquatic Capital Management | 1.1k | $11k | 100% | Mar 2024 |
|
Amalgamated Bank | 818.00 | $8.0k | -66% | Mar 2024 |
|
Advisor Group Holdings | 764.00 | $7.8k | 14% | Mar 2024 |
|
Lindbrook Capital | 700.00 | $7.2k | 0% | Mar 2024 |
|
Pacer Advisors | 516.00 | $5.3k | 100% | Mar 2024 |
|
Daiwa Securities Group | 367.00 | $4.0k | 0% | Mar 2024 |
|
Quadrant Capital | 347.00 | $3.5k | 0% | Mar 2024 |
|
Tower Research Capital | 231.00 | $2.4k | -99% | Mar 2024 |
|
Us Bancorp | 155.00 | $1.6k | 0% | Mar 2024 |
|
Brian McDonald | 140.00 | $1.4k | 100% | Mar 2024 |
|
GAMMA Investing | 100.00 | $1.0k | 32% | Mar 2024 |
|
Hanson McClain Advisors | 82.00 | $838.999400 | 100% | Mar 2024 |
|
C.M. Bidwell & Associates | 48.00 | $491.001600 | 100% | Mar 2024 |
|
Pnc Financial Services | 8.00 | $82.000000 | 0% | Mar 2024 |
|
Nelson, Van Denburg & Campbell Wealth Management | 5.00 | $51.000000 | 100% | Mar 2024 |
|
Who sold out of Silverback Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Charles Schwab Trust | Dec 2023 | 4.0M | $22M |
Baker Bros. Advisors | Dec 2023 | 2.0M | $11M |
Nantahala Capital Management | Dec 2023 | 1.6M | $8.7M |
Tang Capital Management | Dec 2023 | 410k | $2.2M |
Group One Trading | Sep 2023 | 111k | $420k |
Denali Advisors | Dec 2023 | 88k | $480k |
Cubist Systematic Strategies | Dec 2023 | 77k | $423k |
Tejara Capital | Dec 2023 | 74k | $404k |
Simplex Trading | Dec 2023 | 68k | $373k |
Belvedere Trading | Sep 2023 | 31k | $117k |
Brendel Financial Advisors | Dec 2023 | 18k | $100k |
Mirae Asset Global Investments | Dec 2023 | 17k | $91k |
Schonfeld Strategic Advisors | Dec 2023 | 17k | $90k |
ExodusPoint Capital Management | Sep 2023 | 11k | $42k |
XTX Topco | Sep 2023 | 10k | $38k |
AJOVista | Dec 2023 | 7.8k | $43k |
Federated Investors | Sep 2023 | 707.00 | $2.7k |